Company Description
AstraZeneca's products run the gamut from A (breast cancer drug Arimidex) to Z (migraine treatment Zomig). One of the world's...
Key AstraZeneca Financials
| Company Type | Public - NYSE: AZN; London: AZN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $29,559.0 |
| 2007 Employees | 67,900 |
More AstraZeneca Financials (8 pages)
Latest AstraZeneca Jobs jobs by Indeed
Rankings
- Dow Jones STOXX 50
- #136 in FT Global 500
- FTSE 100
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about AstraZeneca's competition across multiple industries
Top AstraZeneca Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
AstraZeneca Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Louis Schweitzer | Network | E-mail |
| CEO and Board Member | David R. Brennan | Network | E-mail |
| Executive Director, Development | John Patterson | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current AstraZeneca News
- Pre-Market Most Actives: Nasdaq [Midnight Trader] (09 Jan 2009 07:56:00 EST)
- Pre-Market Most Active: Nasdaq [Midnight Trader] (07 Jan 2009 08:04:00 EST)
- BioWorld Today January 7, 2009 [BioWorld Today] (07 Jan 2009 00:01:00 EST)
Sponsored Opportunity





